Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**IC2000** is a branded formulation of indocyanine green (ICG), a sterile, water-soluble tricarbocyanine dye used as a near-infrared (NIR) fluorescent imaging agent. It exhibits peak spectral absorption at 800-810 nm in blood plasma and fluoresces when excited by NIR light, enabling real-time intraoperative visualization of lymphatic vessels, lymph nodes, blood flow, and tissue perfusion when used with compatible imaging systems like SPY-PHI or PINPOINT. Administered via intradermal or intravenous injection, it binds highly (98%) to plasma proteins, remains confined to intravascular and lymphatic compartments, undergoes no metabolism, and is rapidly cleared by hepatic uptake and biliary excretion (half-life ~3-4 minutes). Originally developed by Novadaq Technologies (now part of Stryker), it supports lymphatic mapping and sentinel lymph node biopsy in early-stage breast cancer, with applications in various surgical procedures; it has no pharmacological therapeutic effect but aids diagnostic imaging.[1][2][3][4][5][6]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on IC2000.